• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮质类固醇治疗对结节病患者肺血流动力学的影响。

Effects of corticosteroid treatment on pulmonary haemodynamics in patients with sarcoidosis.

作者信息

Gluskowski J, Hawrylkiewicz I, Zych D, Zieliński J

机构信息

Dept of Respiratory Medicine, Institute of Tuberculosis and Lung Diseases, Warsaw, Poland.

出版信息

Eur Respir J. 1990 Apr;3(4):403-7.

PMID:2365034
Abstract

Effects of 12 months steroid treatment on pulmonary haemodynamics in 24 patients with pulmonary sarcoidosis, stage II and III, were investigated. All patients had a chest radiograph, lung function tests, and pulmonary haemodynamics (measured at rest and during submaximal exercise) prior to the treatment. Resting pulmonary hypertension was found in 3 patients. In 18 an abnormal increase in pulmonary arterial mean pressure (PAP) on exercise was observed. All investigations were repeated after a year of treatment. In almost all patients (22) a regression of radiological changes in the lungs and improvement of pulmonary function were observed. The changes in pulmonary circulation were less uniform. In only half of the patients studied was regression of the disease seen on chest X-ray and improvement in lung function accompanied by improvement in pulmonary haemodynamics.

摘要

研究了12个月的类固醇治疗对24例II期和III期肺结节病患者肺血流动力学的影响。所有患者在治疗前均进行了胸部X光检查、肺功能测试和肺血流动力学检查(静息和次极量运动时测量)。3例患者存在静息性肺动脉高压。18例患者在运动时观察到肺动脉平均压(PAP)异常升高。治疗一年后重复进行所有检查。几乎所有患者(22例)肺部的放射学改变均有消退,肺功能得到改善。肺循环的变化不太一致。在仅一半接受研究的患者中,胸部X光片上可见病情消退,肺功能改善并伴有肺血流动力学改善。

相似文献

1
Effects of corticosteroid treatment on pulmonary haemodynamics in patients with sarcoidosis.皮质类固醇治疗对结节病患者肺血流动力学的影响。
Eur Respir J. 1990 Apr;3(4):403-7.
2
[Effect of steroid therapy on pulmonary circulation in pulmonary sarcoidosis].[类固醇疗法对结节病肺循环的影响]
Pneumonol Pol. 1989 Feb;57(2):114-20.
3
Pulmonary haemodynamics at rest and during exercise in patients with sarcoidosis.结节病患者静息和运动时的肺血流动力学
Respiration. 1984;46(1):26-32. doi: 10.1159/000194667.
4
Do chest radiographic findings reflect the clinical course of patients with sarcoidosis during corticosteroid withdrawal?胸部X线检查结果能否反映结节病患者在停用皮质类固醇期间的临床病程?
AJR Am J Roentgenol. 1990 Mar;154(3):481-5. doi: 10.2214/ajr.154.3.2106208.
5
[Pulmonary sarcoidosis and lung function (author's transl)].
Prax Pneumol. 1974 Feb;28(2):99-108.
6
Two asymptomatic cases with sarcoidosis demonstrated sequential evolution from radiographic stage I to III within five years.
Hiroshima J Med Sci. 1999 Sep;48(3):101-3.
7
Corticosteroid therapy in sarcoidosis. A five-year, controlled follow-up study.
N Y State J Med. 1987 Sep;87(9):496-9.
8
Extended experience in the long-term corticosteroid treatment of pulmonary sarcoidosis.在肺结节病长期皮质类固醇治疗方面的丰富经验。
Ann N Y Acad Sci. 1976;278:722-31. doi: 10.1111/j.1749-6632.1976.tb47087.x.
9
Sarcoidosis: a correlation of dyspnea with roentgenographic stage and pulmonary function changes.
Mayo Clin Proc. 1974 Oct;49(10):742-5.
10
Exercise testing in pulmonary sarcoidosis.结节病的运动试验
Chest. 1983 Jan;83(1):75-81. doi: 10.1378/chest.83.1.75.

引用本文的文献

1
Sarcoidosis-Associated Pulmonary Hypertension.结节病相关的肺动脉高压
Medicina (Kaunas). 2025 Feb 14;61(2):342. doi: 10.3390/medicina61020342.
2
Sarcoidosis-Associated Pulmonary Hypertension.结节病相关性肺动脉高压
J Clin Med. 2024 Apr 2;13(7):2054. doi: 10.3390/jcm13072054.
3
Comorbidities of sarcoidosis.结节病的合并症。
Ann Med. 2022 Dec;54(1):1014-1035. doi: 10.1080/07853890.2022.2063375.
4
Epidemiology, Pathogenesis, and Clinical Approach in Group 5 Pulmonary Hypertension.5型肺动脉高压的流行病学、发病机制及临床处理方法
Front Med (Lausanne). 2021 Mar 25;7:616720. doi: 10.3389/fmed.2020.616720. eCollection 2020.
5
Pulmonary hypertension secondary to pulmonary fibrosis: clinical data, histopathology and molecular insights.肺纤维化继发肺动脉高压:临床数据、组织病理学和分子研究进展。
Respir Res. 2020 Nov 18;21(1):303. doi: 10.1186/s12931-020-01570-2.
6
Treatment of newly diagnosed sarcoid-associated pulmonary hypertension with ambrisentan and tadalafil combination therapy.使用安立生坦和他达拉非联合疗法治疗新诊断的结节病相关肺动脉高压。
Sarcoidosis Vasc Diffuse Lung Dis. 2020;37(2):234-238. doi: 10.36141/svdld.v37i2.9343. Epub 2020 Jun 30.
7
Long-term outcomes of epoprostenol therapy in sarcoid associated pulmonary hypertension.依前列醇治疗结节病相关肺动脉高压的长期疗效
Sarcoidosis Vasc Diffuse Lung Dis. 2020;37(2):184-191. doi: 10.36141/svdld.v37i2.9150. Epub 2020 Jun 30.
8
Pulmonary vascular and cardiac impairment in interstitial lung disease.间质性肺疾病中的肺血管和心脏损害
Eur Respir Rev. 2017 Jan 17;26(143). doi: 10.1183/16000617.0053-2016. Print 2017 Jan.
9
Sarcoidosis-associated pulmonary hypertension and lung transplantation for sarcoidosis.结节病相关性肺动脉高压与结节病肺移植。
Semin Respir Crit Care Med. 2014 Jun;35(3):362-71. doi: 10.1055/s-0034-1376863. Epub 2014 Jul 9.
10
Right ventricular dysfunction in chronic lung disease.慢性肺部疾病中的右心室功能障碍。
Cardiol Clin. 2012 May;30(2):243-56. doi: 10.1016/j.ccl.2012.03.005.